HLA antigens in asymptomatic diabetes. A 10-year follow-up study of potential diabetes in pregnancy and gestational diabetes. by Mawhinney, H. et al.
HLA ANTIGENS IN ASYMPTOMATIC DIABETES. A 10-YEAR
FOLLOW-UP STUDY OFPOTENTIAL DIABETES IN
PREGNANCY AND GESTATIONAL DIABETES
by
HELEN MAWHINNEY, D. R. HADDEN, DEREK MIDDLETON,
J. M. G. HARLEY and D. A. D. MONTGOMERY
Department ofMedicine, The Queen's University ofBelfast
Metabolic Unit, Royal Victoria Hospital
Tissue Typing Laboratory, Belfast City Hospital
Ante-natal Diabetic Clinic, Royal Maternity Hospital, Belfast
INTRODUCTION
BOTH genetic and environmental factors have been implicated in the pathogenesis
of diabetes mellitus. Juvenile-onset diabetes mellitus has been shown to be
associated with increased frequencies of HLA-B8 and HLA-B15 (Nerup et al, 1974;
Cudworth and Woodrow, 1975) and it is believed that a major genetic factor in this
type of diabetes is the presence of a diabetogenic gene or genes linked to the major
histocompatibility complex. While twin studies have suggested that genetic factors
are also important in maturity-onset diabetes (Tattersall and Pyke, 1972) a definite
association between antigens of the major histocompatibility complex and maturity-
onset diabetes has not been demonstrated (Nerup et al, 1974; Cudworth and
Woodrow, 1976)..
Studies of genetic factors in diabetes mellitus have hitherto been confined mainly
to symptomatic diabetes rather than asymptomatic diabetes, such as that which may
occur in pregnancy. The relationship between this form of asymptomatic diabetes
and symptomatic diabetes mellitus in later life is poorly understood. In particular,
although some women with transiently abnormal glucose tolerance in pregnancy
eventually develop symptomatic maturity-onset diabetes, it is uncertain whether
they are at greater risk of doing so than the normal population (O'Sullivan, 1975;
Hadden, 1979). Genetic factors may have a role in either the pathogenesis of
asymptomatic diabetes in pregnancy or its subsequent progression to symptomatic
maturity-onset diabetes.
As part of a long-term follow-up study (Hadden, 1979) we have examined the
frequencies of HLA-B8 and HLA-B15 in women who had transiently abnormal
glucose tolerance in an index pregnancy i.e. "gestational diabetics" and women
regarded as having "potential diabetes in pregnancy" on the basis of selection
criteria during the index pregnancy (previous big baby, family history of diabetes,
etc) and have correlated our findings with the results of oral glucose tolerance tests
10 years later.
166PATIENTS AND METHODS
Two groups of patients were studied. Group 1 consisted of 32 patients who had
been classified during an index pregnancy as having "potential diabetes in
pregnancy" and who were found to have an abnormal glucose tolerance test (GTT)
at 10 year follow-up. This group was obtained from 625 patients attending the
Antenatal Clinic of the Royal Maternity Hospital, Belfast between 1963 and 1965
who fulfilled one or more of the criteria for the diagnosis of potential diabetes in
pregnancy in previous pregnancies or in the index pregnancy (Hadden and Harley,
1967). Of these, 234 attended for a 50g oral GTT 10 years later as part of a long
term follow-up study and 32 were found to have abnormal glucose tolerance (2 hour
plasma glucose greater than 7.2 mmol/1) (Hadden, 1979). Tissue typing was carried
out in all ofthese 32 patients.
Group 2 consisted of 83 patients who had been classified during an index
pregnancy as having "gestational diabetes". Between 1966 and 1968 over 1000
mothers attending the Antenatal Clinic of the Royal Maternity Hospital, Belfast
fulfilled the selection criteria for the diagnosis of potential diabetes in pregnancy
and had either an intravenous GTT or a cortisone-stressed oral GTT (Hadden et al,
1971). Of these 216 were shown to have an abnormal GTT in the index pregnancy.
Frankly diabetic patients were excluded from the study. Ninety-three of these
patients attended for a 50g oral GTT 10 years later. Tissue typing was carried out
in 83 ofthese patients, 15 ofwhom had an abnormal GTT at follow-up.
At follow-up 10 years after the index pregnancy the patients were classified
according to the results of a 50g oral GTT as "normal" (2 hour plasma glucose less
than 7.2 mmol/1), "borderline" (2 hour plasma glucose 7.2-8.29 mmol/1) or
"diabetic" (2 hour plasma glucose greater than 8.3 mmol/1). All patients with 2
hour plasma glucose greater than 7.2 mmol/I were considered to be "abnormal".
Two hundred normal blood donors resident in the same geographical area and
tissue-typed concurrently with the patients were used as controls. Typing for
HLA-B8 and HLA-B15 was carried out by a standard microlymphocytoxicity test.
In each instance not less than 3 different antisera of each specificity were used.
Antisera against HLA-B15 were obtained from the National Tissue Typing
Reference Laboratory, Bristol. Antisera against HLA-B8 were obtained locally and
their specificity was checked in two other laboratories. Statistical analysis was
carried out using the exact probability test.
RESULTS
Of the 32 patients (group 1) with potential diabetes in pregnancy who had
abnormal GTT's 10 years later, 9 were classified as diabetic and 23 as borderline.
The frequencies of HLA-B8 and HLA-B15 in this group compared with the 200
control subjects are shown in Table I. A significantly increased frequency of
HLA-B15 but not HLA-B8 was found in this group compared with control subjects.
This difference was due solely to the frequency of HLA-B15 in those patients
classified as borderline.
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Frequencies of HLA-B8 and HLA-BJS in 32 patients with potential diabetes in
pregnancy who had abnormal glucose tolerance tests atfollow-up compared with
200 control subjects.
HLA-B8 HLA-B15
Number Number Percent Number Percent
studied positive positive Probability positive positive Probability
Blood donors 200 69 34.5 9 4.5
Abnormal at follow-up 32 9 28.1 0.4277 6 18.8 0.0087
(i) Diabetic
at follow-up 9 3 33.3 0.9999 0 0 0.9998
(ii) Borderline
at follow-up 23 6 26.1 0.3666 6 26.1 0.0017
Ofthe 83 patients (group 2) withgestational daibetes, 7 were classified as diabetic,
8 as borderline and 68 as normal on the basis of their follow-up GTT's. The
frequencies of HLA-B8 and HLA-B15 in this group compared with the 200 normal
control subjects are shown in Table II. In the group as a whole and in those who
were classified as normal at follow-up, but not in those who were abnormal at
follow-up, the frequency of HLA-B8 was significantly decreased. The frequency
of HLA-B15 in this group was nearly twice that of the control population, but this
increase was not statistically significant.
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68 13 19.1 0.0097
15 4 26.7 0.5806
7 1 14.3 0.4249











Of the 115 patients (groups 1 and 2) studied, 47 had an abnormal GTT at follow-
up i.e. they had asymptomatic diabetes 10 years after an index pregnancy in which
they had potential diabetes in pregnancy or gestational diabetes. The relativefrequencies of HLA-B8 and HLA-B15 in these asymptomatic diabetics are shown
in Table III. Once again there was a significant increase in the frequency of
HLA-B15 compared with control subjects and this increase was due solely to those
patients classified as borderline at follow-up. There was however, no statistically
significant difference between the frequency of HLA-B15 in the borderline group
compared with the diabetic group (p=0.0782) or with the group who were normal
at follow-up (p=0.1044).
TABLE III
Frequencies ofHLA-B8 and-HLA-B15 in 47patients with eitherpotential diabetes
in pregnancy or gestational diabetes who had abnormal glucose tolerance tests at
follow-up compared with 200controlsubjects.
HLA-B8 HLA-BJ5
Number Number Percent Number Percent
studied positive positive Probability positive positive Probability
Blood donors 200 69 34.5 - 9 4.5
Abnormal at follow-up 47 13 27.7 0.3062 7 14.9 0.0170
(i) Diabetic
at follow-up 16 4 25.0 0.4269 0 0 1.0000
(ii) Borderline
at follow-up 31 9 29.0 0.5443 7 22.6 0.0019
DISCUSSION
In this study HLA-B15 appears to be associated with abnormal glucose tolerance
10 years after an index pregnancy in which a woman was considered to have either
gestational diabetes or potential diabetes in pregnancy. The frequency of HLA-B15
in these patients was comparable with that found in juvenile-onset diabetes in
several series (Nerup et al, 1974; Cudworth and Woodrow, 1975) and in addition
the frequency of HLA-B15 in our Northern Ireland control population was almost
identical to that found in a large series in the Bristol area (Middleton and Martin,
1978). In contrast the frequency of HLA-B15 was only slightly increased in an
unselected series of gestational diabetics. Although an unselected series of patients
with potential diabetes in pregnancy was not examined in this study a similar
absence of any significant HLA association might be expected especially since
potential diabetes in pregnancy comprises a very heterogeneous group of patients.
In this study therefore the increased frequency of HLA-B15 is associated with
asymptomatic diabetes in middle life rather than with the original criteria for
inclusion in the follow-up study. This study does not, however, suggest a correlation
between HLA-B15 and progression from gestational diabetes or potential diabetes
in pregnancy to symptomatic maturity-onset diabetes. In our series of patients who
have now been followed from 10 to 15 years the incidence of symptomatic diabetes
is very low and may be no greater than would be expected in a comparable group
of the female population (Hadden et al, 1979). We cannot predict whether our
patients who now have abnormal oral GTT's will eventually become symptomatic
maturity-onset diabetics but prolonged follow-up is obviously required.
169There have been several studies of the frequency of HLA antigens in maturity-
onset diabetes but, in contrast to juvenile-onset diabetes no definite association
with any HLA antigen has been found (Nerup et al, 1974; Cudworth and Woodrow,
1976). The association of asymptomatic diabetes with an increased frequency of
HLA-B15 in this study therefore favours the suggestion that asymptomatic glucose
intolerance does not necessarily progress to symptomatic maturity-onset diabetes.
In this respect it is of interest that the increased frequency of HLA-B15 occurs
predominantly in those women whose glucose tolerance tests were classified as
"borderline" rather than "diabetic". It is thus possible that this study has revealed
two subgroups of asymptomatic diabetes; (a) those with diabetic glucose tolerance
tests in whom there is no HLA association and who may eventually become
symptomatic maturity-onset diabetics and (b) those with mildly abnormal glucose
tolerance tests associated with an increased frequency of HLA-B15 and in whom
the outcome is uncertain.
A rather unexpected finding in this study was the decreased frequency of HLA-B8
in those patients with gestational diabetes compared with the control population,
the difference being due mainly to the decreased frequency of HLA-B8 in those
patients with gestational diabetes who had normal glucose tolerance at follow-up.
This appears to be a true decrease in the frequency of HLA-B8 in the gestational
diabetics rather than a falsely high frequency of HLA-B8 in the control population
since the frequency of HLA-B8 has recently been shown to be higher in Northern
Ireland, in common with other parts of Ireland, compared with other areas in the
British Isles (Middleton and Martin, 1978). No obvious explanation exists for the
decreased frequency ofHLA-B8 in thegestational diabetics but it is perhaps relevant
that patients who were already frankly diabetic during the index pregnancy and who
might be expected to have an increased frequency of HLA-B8 were excluded from
the study.
In most instances in which an increased frequency of HLA-B15 has been
associated with symptomatic diabetes there has been a concomitant increase in the
incidence of HLA-B8 (Nerup et al, 1974; Cudworth and Woodrow, 1975).
Cudworth and Woodrow (1976) found that in juvenile-onset diabetics the relative
risk was additive when both HLA-B8 and HLA-B15 were present. They suggested
that this finding was in favour of there being more than one HLA-linked gene,
possibly operating by different mechanisms, involved in the pathogenesis of
juvenile-onset diabetes. It may therefore be that our patients in whom HLA-B15
is associated with asymptomatic impaired glucose tolerance have lacked an
additional genetic or environmental factor which would have favoured the
development of juvenile-onset diabetes. In favour of this suggestion is the finding
of Nelson et al (1975) that there is an increased frequency of HLA-B15 but not
HLA-B8 in identical twins discordant for juvenile-onset diabetes. This suggests that
an HLA-B15 linked diabetogenic gene may not necessarily be phenotypically
expressed.
The mechanisms by which HLA-linked disease susceptibility genes result in
expression of the disease concerned are uncertain but one possibility is that such
genes determine susceptibility to virus infection. There is good evidence that virus
infection can result in diabetes in experimental animals (Craighead, 1975) but in
human diabetes the evidence in favour ofinitiating virus infection e.g. by Coxsackie
170B4 virus, is much weaker (Gamble, Taylor and Cumming, 1973; Hadden et al,
1972). Cudworth et al (1977) have produced evidence that HLA-B15 positive
juvenile-onset diabetics have higher neutralising antibody titres to Coxsackie virus
types B1-B4 at the time of diagnosis. Antibody titres to Coxsackie virus were not
determined in this study. Further work is required to determine the mechanism by
which the presence of HLA-B15 or an HLA-B15 linked gene may lead to the
development ofasymptomatie diabetes mellitus.
SUMMARY
In a 10-year follow-up study the frequencies of HLA-B8 and HLA-B15 were
examined in women classified in an index pregnancy as having potential diabetes
in pregnancy or gestational diabetes. In 32 patients who had been considered as
having potential diabetes in pregnancy and who had an abnormal GTT ten years
later, the frequency of HLA-B15 (18.8 per cent) was significantly increased
compared with 200 control subjects (4.5 per cent; p=0.0087). In 83 patients
originally classified as having gestational diabetes, 15 of whom had an abnormal
GTT ten years later, the frequency of HLA-B15 (8.4 per cent) showed a small
increase compared with controls (4.5 per cent; p=0.2561) while the frequency of
HLA-B8 (20.5 per cent) was significantly lower than controls (34.5 per cent;
p=0.0106).
Of a total of 115 patients studied 47 had an abnormal GTT at follow-up and in
these 47 patients the frequency of HLA-B1-5 was also significantly increased
compared with controls (14.9 per cent; p=0.017). This increase was most marked
in those women with borderline GTT (22.6 per cent; p = 0.0019).
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BOOK REVIEW
MANUAL OF GYNAECOLOGIC AND OBSTETRIC EMERGENCIES. By B.
Taber, M.D. (Pp 929. Illustrated. £17.25). Philadelphia, London, Toronto:
W. B. Saunders and Eastbourne; Holt-Saunders. 1979.
THERE is little doubt that one can find in this book hints on the management ofalmost every emergency
possible in obstetrics and gynaecology. There is information on topics as far ranging as breech
presentation to burns and syncope to sexual assault.
The book is well laid out with a good index and each subject is discussed in a similar and logical
manner. The information is sound and supported by illustrations and recent references although some
procedures and drugs have a strongAmerican flavour.
It is not unreasonable to ask what place there is for a manual devoted to emergency procedures and
one must agree with the sentiments ofthe emergency physician writing the foreword that "in the various
fields of medicine the chances are that a knowledge of obstetrics and gynaecology will be necessary at
some time or another". Although he suggests that the manual may fill the need of the psychiatrist,
dermatologist, orthopaedic or general surgeon faced with a problem, I find it difficult to agree with him
that it will be read by any physician who might ask himself "Do I know enough of the most wondrous
elements ofthephysiology ofthe female ofour species?"
However, this book would be of use to specialists in other fields and indeed to general practitioners
who wish to remind themselves what is current practice in a wide variety of situations in obstetrics and
gynaecology. J.W.K.R.
ERRATUM
It is regretted that the portrait of Mr. T. S. Holmes (Figure 1 page 9 of the
previous number) was incorrectly named Mr. H. P. Hall.
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